All ILMN Content

Illumina, Inc (ILMN) Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 25, 20261 min read

Illumina, Inc (ILMN) Illumina launches TruPath Genome, setting a new standard in genomic insight

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 24, 20261 min read

Illumina, Inc (ILMN) Illumina Unveils Roadmap Of Groundbreaking Novaseq X Advancements In Data Quality, Output, Speed, And Flexibility

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 23, 20261 min read

Illumina, Inc (ILMN) Q4 2025 Earnings Call

Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference

February 17, 20261 min read

Illumina, Inc (ILMN) Q4 2025 Earnings Call

Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference

February 17, 20261 min read

Illumina, Inc (ILMN) TD Cowen 46th Annual Health Care Conference 2026

Illumina, Inc (NASDAQ: ILMN) FY 2026 Corporate Conference

February 17, 20261 min read

Illumina, Inc (ILMN) Sec Form 10K

Illumina, Inc (NASDAQ: ILMN) Sec Form 10K

February 13, 20261 min read

Illumina, Inc (ILMN) AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 10, 20261 min read

Illumina, Inc (ILMN) Sec Form 8K

Illumina, Inc (NASDAQ: ILMN) Sec Form 8K

February 7, 20261 min read

Illumina, Inc (ILMN) Q2 2025 Earnings Call Transcript

Illumina, Inc (NASDAQ: ILMN) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Brian Blanchett — Head of Investor Relations Jacob Thaysen — Chief…

January 22, 202646 min read